Peer-Reviewed Publication
J Pathol Inform2021;1217.January 1, 2021Journal Article

Dissecting the Business Case for Adoption and Implementation of Digital Pathology: A White Paper from the Digital Pathology Association.

Giovanni Lujan1, Jennifer C Quigley2, Douglas Hartman3, Anil Parwani1, Brian Roehmholdt4, Bryan Van Meter5, Orly Ardon6, Matthew G Hanna6, Dan Kelly7, Chelsea Sowards8, Michael Montalto9, Marilyn Bui10, Mark D Zarella11, Victoria LaRosa12, Gerard Slootweg13, Juan Antonio Retamero13, Mark C Lloyd14, James Madory15, Doug Bowman16
1Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
2LabCorp Oncology, Burlington, NC, USA.
3Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
4Department of Pathology, Southern California Permanente Medical Group, La Canada Flintridge, CA, USA.
5Barco, Inc. Wauwatosa, WI, USA.
6Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7Inform Diagnostics Irving, TX, USA.
8LUMEA Lehi, UT, USA.
9PathAI Boston, MA 02215, USA.
10Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
11Johns Hopkins Medicine Pathology Informatics, Baltimore, MD 21287, USA.
12Education Services Department, Oracle Corp, Austin, Texas, USA.
13Philips, Best, NL, The Netherlands.
14Inspirata, Inc. Tampa, FL, USA.
15Department of Pathology, Medical University of South Carolina, Charleston, SC, USA.
16Indica Labs Corrales, NM, USA.

Abstract

We believe the switch to a digital pathology (DP) workflow is imminent and it is essential to understand the economic implications of conversion. Many aspects of the adoption of DP will be disruptive and have a direct financial impact, both in short term costs, such as investment in equipment and personnel, and long term revenue potential, such as improved productivity and novel tests. The focus o…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.